Gymnosporia parviflora
Gymnosporia parviflora · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Gymnosporia parviflora is a versatile medicinal plant recognized for its diverse therapeutic potential in traditional medicine. Scientific investigations have highlighted its significant biological properties, particularly its ability to combat various pathogens. Among its most notable pharmacological profiles is its potent antiprotozoal activity, which offers promise in treating parasitic infections. Researchers continue to explore the chemical constituents of this species to better understand its healing mechanisms. Consequently, this plant stands as a valuable subject of study for developing new natural treatments against protozoan diseases.
- Synonyms
- Maytenus Parviflora · Celastrus Parviflorus · 1 more
- Common names
- Not available
- Family
- Not available
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Gymnosporia parviflora is a botanical species that is frequently identified by various other scientific names in academic literature. Due to historical taxonomic shifts, it is recognized by the synonym Catha parviflora in certain records. Researchers may also encounter this plant documented under the name Celastrus parviflorus. Additionally, the species has been classified as Maytenus parviflora in previous botanical studies. Understanding these various synonyms is essential for ensuring accurate identification and communication within the scientific community.
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Gymnosporia parviflora exhibits a wide and diverse geographic range spanning across two major continents. In Africa, this species is notably distributed throughout Northeast Tropical Africa, including the regions of Eritrea and Somalia. Its presence extends further into the Asia-Temperate zone, specifically within the arid landscapes of the Arabian Peninsula. Within this peninsula, the plant can be found thriving in both Saudi Arabia and Yemen. This broad distribution highlights the plant's ability to adapt to various environmental conditions across these distinct territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Gymnosporia parviflora is characterized by its distinctive shrubby growth form.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Gymnosporia parviflora has demonstrated significant antiprotozoal activity in recent in vitro evaluations. Research focused on assessing various medicinal plants against major pathogens, including those responsible for sleeping sickness, Chagas disease, and leishmaniasis. Among the tested species, this plant showed promising potency against specific parasites such as Trypanosoma brucei brucei and Trypanosoma b. rhodesiense. The study also highlighted the plant's relevant selectivity, indicating a favorable balance between effectiveness and low cytotoxicity. These findings suggest that the species holds considerable potential for further pharmacological development in treating protozoan infections.
Compounds
Conditions
Gymnosporia parviflora, identified in the research as Maytenus parviflora, demonstrates significant antiprotozoal activity against specific parasites. The plant exhibits high potency in treating Trypanosoma brucei brucei with an IC50 value of 0.6 μg/ml. It also shows effective results against Trypanosoma b. rhodesiense, achieving an IC50 of 0.5 μg/ml. These findings highlight the plant's ability to combat these agents of sleeping sickness while maintaining low cytotoxicity. Consequently, the species proves to be a highly selective and effective medicinal candidate for these particular protozoan infections.